Your browser doesn't support javascript.
loading
Cell-specific gene therapy driven by an optimized hypoxia-regulated vector reduces choroidal neovascularization.
Biswal, Manas R; Prentice, Howard M; Smith, George W; Zhu, Ping; Tong, Yao; Dorey, C Kathleen; Lewin, Alfred S; Blanks, Janet C.
Afiliação
  • Biswal MR; Integrative Biology Program, Dept. of Biology, Florida Atlantic University, Boca Raton, FL, USA.
  • Prentice HM; Department of Molecular Genetics and Microbiology, University of Florida College of Medicine, Gainesville, FL, USA.
  • Smith GW; Charles E. Schmidt College of Medicine, Florida Atlantic University, 777 Glades Road, Boca Raton, FL, 33431, USA. hprentic@health.fau.edu.
  • Zhu P; Center for Complex Systems and Brain Sciences, Florida Atlantic University, Boca Raton, FL, USA. hprentic@health.fau.edu.
  • Tong Y; Integrative Biology Program, Dept. of Biology, Florida Atlantic University, Boca Raton, FL, USA.
  • Dorey CK; Department of Ophthalmology, University of Florida College of Medicine, Gainesville, FL, USA.
  • Lewin AS; Department of Molecular Genetics and Microbiology, University of Florida College of Medicine, Gainesville, FL, USA.
  • Blanks JC; Virginia Tech Carilion School of Medicine, Roanoke, VA, USA.
J Mol Med (Berl) ; 96(10): 1107-1118, 2018 10.
Article em En | MEDLINE | ID: mdl-30105447

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Terapia Genética / Neovascularização de Coroide / Hipóxia Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Terapia Genética / Neovascularização de Coroide / Hipóxia Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Ano de publicação: 2018 Tipo de documento: Article